Intratect Indications/Uses

Intratect is used in adults, and children and adolescents (0-18 years) who do not have sufficient antibodies (replacement therapy) in cases of: Patients born with lack of antibodies (primary immunodeficiency syndromes).
Hypogammaglobulinemia and repeated bacterial infections in patients with chronic lymphocytic leukaemia, in whom prophylactic antibiotics have failed.
Hypogammaglobulinaemia and repeated bacterial infections in plateau phase multiple myeloma patients who have failed to respond to pneumococcal immunisation.
Hypogammaglobulinaemia in patients after allogeneic haematopoietic stem cell transplantation (HSCT).
Congenital AIDS with recurrent bacterial infections.
Intratect is also used in adults, and children and adolescents (0-18 years) to treat inflammatory disorders (immunomodulation) such as: Primary immune thrombocytopenia (ITP, where a patient has reduced blood platelets) when the patient will have surgery in the near future or is at risk of bleeding.
Guillain-Barré syndrome (a disease that damages nerves and may lead to generalised palsy).
Kawasaki disease (a disease in children which causes inflammations of several organs of the body and where the arteries in the heart become enlarged).